In that study, TIGIT expression was increased on the AD patients’ CD4+ T cells to impede chronic skin inflammation, and TIGIT expression may be impaired in some AD patients, leading to the deterioration of skin inflammation (77, 195). The gene discussed is TIGIT; the disease is dermatitis.